Staska Pharmaceuticals is recalling 4,773 vials of Ascorbic Acid (Vitamin C) Injection Solution due to the presence of glass particles inside the vials. The recall affects 50mL single-use vials with a concentration of 25,000mg/50mL. Healthcare providers and medical offices should stop using these vials immediately to avoid serious health risks and contact the manufacturer to arrange for a return.
Injecting a solution containing glass fragments can lead to severe health consequences, including blood vessel blockages in the lungs or other organs, internal inflammation, and swelling at the injection site.
Compounded drug for IV use. Labeled for office use only. Manufactured on 07/12/2024.
“Ascorbic Acid Inj. Solution 25,000mg/50ml (500mg/ml), Rx only, STASK Pharmaceuticals”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.